SEC Filing Summary
Filing identity: The provided 10-K is for Silver Spike Investment Corp. (Nasdaq: SSIC), not Chicago Atlantic BDC, Inc. The filing describes a proposed portfolio acquisition and expected rebranding to Chicago Atlantic BDC, Inc., subject to closing conditions and approvals.
Business context and reporting period
Annual report for the fiscal year ended December 31, 2023, filed March 27, 2024. Silver Spike is an externally managed, non-diversified BDC and RIC focused primarily on lending to cannabis-related businesses. Its fiscal year-end changed from March 31 to December 31; therefore, the main year-over-year comparison is a full 2023 year against the nine months ended December 31, 2022, not equivalent periods.
Financial and portfolio highlights
| Metric | 2023 / year-end | Comparable prior period / year-end |
|---|---|---|
| Investment income | $11.93 million | $4.04 million for nine months ended December 31, 2022 |
| Net investment income | $6.63 million; $1.07 per share | $2.20 million; $0.35 per share for nine months ended December 31, 2022 |
| Net increase in net assets from operations | $7.34 million; $1.18 per share | $1.92 million; $0.31 per share for nine months ended December 31, 2022 |
| Operating expenses | $5.30 million | $1.84 million for nine months ended December 31, 2022 |
| Cash from operating activities | $5.75 million | $(49.64) million for nine months ended December 31, 2022, largely reflecting investment purchases |
| Cash and cash equivalents | $32.61 million | $35.13 million at December 31, 2022 |
| Debt | No indebtedness | No indebtedness |
| Net assets / NAV per share | $85.55 million / $13.77 | $86.48 million / $13.91 at December 31, 2022 |
| Investment portfolio fair value | $54.12 million across five companies | $50.25 million across five companies |
Interest income rose to $11.74 million from $3.63 million in the prior nine-month period. Management attributed the increase to the full-year contribution of investments made in 2022, additional investment deployment, higher floating rates, three additional reporting months, and a one-time prepayment premium. Expenses increased with scaled operations and included $711,264 of acquisition-related transaction costs. The filing’s financial highlights report 2023 expenses at 6.01% and net investment income at 7.52% of average net assets; these ratios are not annualized as presented.
2023 investment activity included approximately $8.44 million of purchases and $6.21 million of repayments or sales. Realized investment loss was $210,767; net unrealized appreciation was $922,031. All portfolio investments were rated 2 under the company’s internal scale, and none were on non-accrual. However, all investments were Level 3 fair-value measurements requiring significant unobservable inputs. Two portfolio companies represented 77.0% of portfolio fair value.
The company declared $8.27 million of quarterly and special distributions in 2023, or $1.33 per share in total. Net investment income was $6.63 million. The filing cautions that distributions may exceed earnings and may include return of capital. Cash declined by $2.51 million during 2023, reflecting operating cash generation offset by distributions and other activity.
Material changes and market performance
- Portfolio fair value increased by about $3.87 million year over year; first-lien term loans rose to 85.0% of investments from 80.9%, while secured notes declined to 15.0% from 19.1%.
- Floating-rate investments accounted for 84.1% of debt principal at year-end, up from 79.6%; fixed-rate investments were 15.9%. The company had no borrowing expense, so reported rate sensitivity reflects investment income.
- NAV per share decreased to $13.77 from $13.91. Total return based on NAV was 13.65% for 2023, while total return based on market value was negative 13.88%.
- At March 22, 2024, the stock closed at $9.80, a reported 28.8% discount to December 31, 2023 NAV.
- The portfolio remained concentrated in cannabis wholesale trade, with geographic exposure concentrated in the West and Midwest.
Outlook, transactions, and risks
Management cited an approximately $422 million pipeline of potential investments under review, but provided no earnings or distribution guidance. It expected cannabis capital-market activity to remain muted pending federal rescheduling developments, while anticipating continued demand for credit. These are expectations, not assured outcomes.
On February 18, 2024, the company agreed to acquire all or substantially all of Chicago Atlantic Loan Portfolio, LLC’s loan portfolio in exchange for newly issued SSIC shares. The portfolio comprised 24 loans valued at approximately $130 million as of January 1, 2024; CALP agreed to use reasonable best efforts to add four loans totaling approximately $43 million before closing. The transaction was expected to close in mid-2024, subject to conditions including stockholder approval, final valuation, and other customary requirements. Based on stated assumptions, existing SSIC holders would own approximately 38.4% and CALP approximately 61.6% after closing. A $6.05 million termination fee may apply in specified circumstances.
A separate adviser joint venture with Chicago Atlantic was announced, which would trigger termination of the current advisory agreement; a substantially similar replacement agreement requires stockholder approval. The company also approved an expansion of its investment strategy to allow investments beyond cannabis and health and wellness, expected to take effect on or about April 22, 2024. The company said it would be renamed Chicago Atlantic BDC, Inc. upon effectiveness of the new advisory agreement.
- Key risks: cannabis remains illegal under U.S. federal law; state and federal regulatory changes, limited banking access, and restrictions on collateral or bankruptcy remedies could impair borrowers and recoveries.
- Concentration, illiquidity, below-investment-grade credit exposure, covenant-lite loan risk, and subjective Level 3 valuations may affect NAV and realized returns. Rising rates may benefit floating-rate income but also weaken borrowers’ ability to service debt.
- RIC qualification and distribution requirements may require cash distributions even when income includes non-cash OID or PIK accruals. Adviser fees include a 1.75% base fee on specified gross assets and incentive fees.
- The proposed acquisition carries closing, integration, dilution, valuation, and termination risks. The filing estimates substantial dilution of current holders if it closes.
No material legal proceedings, identified material cybersecurity incidents, or commitments and contingencies were reported. Management concluded disclosure controls and internal control over financial reporting were effective at year-end; the auditor did not attest to internal control effectiveness because the company is an emerging growth company. The auditor gave an unqualified opinion on the financial statements.
Important facts for investors to verify
- Confirm the issuer identity: this filing is Silver Spike Investment Corp. (SSIC); Chicago Atlantic BDC, Inc. is a proposed future name, not the reporting company’s name in this 10-K.
- Review the acquisition’s final loan portfolio, independent valuation inputs, share issuance, ownership split, stockholder vote, and any subsequent closing or termination disclosures.
- Assess the Level 3 valuation assumptions and concentration in the two largest borrowers; verify borrower performance and collateral enforceability, particularly for cannabis-related assets.
- Reconcile declared distributions with taxable income, cash receipts, and any return-of-capital characterization; assess the effect of PIK/OID income on liquidity.
- Compare future results on consistent twelve-month periods, given the reporting-period change, and monitor NAV, stock discount, liquidity, and any new leverage.